(1)
Wollenberg, A.; Howell, M. D.; Guttman-Yassky, E.; Silverberg, J. I.; Birrell, C.; Kell, C.; Ranade, K.; Dawson, M.; van der Merwe, R. A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients With Moderate to Severe Atopic Dermatitis. J of Skin 2018, 2, S29.